Irene Hadjiyanni1, Daniel J Drucker. Show Affiliations » 1. Department of Medicine, Samuel Lunenfeld Research Institute, Mt Sinai Hospital, SLRI 975C, Toronto, Ontario, Canada.
Abstract
Entities: Disease Gene
Mesh： See more » AnimalsAntibodies/therapeutic useCD3 Complex/immunologyCombined Modality TherapyDiabetes Mellitus, Type 1/etiologyDiabetes Mellitus, Type 1/therapyExenatideGlucagon-Like Peptide 1/physiologyGlucagon-Like Peptide-1 ReceptorImmunotherapyMiceMice, Inbred NODModels, BiologicalPeptides/therapeutic useReceptors, Glucagon/agonistsTreatment OutcomeVenoms/therapeutic use
Substances： See more » AntibodiesCD3 ComplexGlp1r protein, mouseGlucagon-Like Peptide-1 ReceptorPeptidesReceptors, GlucagonVenomsGlucagon-Like Peptide 1Exenatide
Year: 2007 PMID： 17940186 DOI： 10.1210/en.2007-1112
Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736